Clinical Trials Directory

Trials / Unknown

UnknownNCT00187993

Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

Growth Hormone Treatment of Young Adults Deficient in Growth Hormone Since Childhood : Study of Body Composition Modifications.

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (planned)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Hypopituitary adults with all the hormonal deficiencies are well subsituted excepted for the growth hormone (GH) and died earlier than the rest of the population. GH deficiency involves a fat mass increase with regard to lean mass, an atherogenic lipidic profile and participating to osteopenia mechanism and decrease the life quality. All these dysfunctions are partially or totally corrected by the GH prescription with patient deficient since adulthood. However, for patients deficient since childhood, no study have demonstrated that GH treatment during childhood present these same benefit when they are treated during adulthood. Primary objective of this study is to examine that fat mass significantly decrease due to GH treatment in adulthood for patient GH deficient since childhood, treated by GH during childhood but stopped since the end of adolescence. We compare the body composition and others energetic metabolism parameters in two patient groups, one treated by GH during 18 months, and the other with no treatment. Body composition and bone density are measured by pletysmography (DEXA). Metabolic parameters are : energetic balance (energy intake evaluation by questionnaire, energetic expenditure evaluated by doubly labelled water) and biologic parameters (lipidic profile, thyroid hormones). This study will evaluate if the GH treatment of young GH deficient adults since childhood can be a benefit for body composition, lipidic profile and bone density.

Conditions

Interventions

TypeNameDescription
DRUGGrowth hormone

Timeline

Start date
2005-05-01
Completion
2005-08-01
First posted
2005-09-16
Last updated
2005-09-16

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00187993. Inclusion in this directory is not an endorsement.